A new non-invasive technique that can detect disease biomarkers in blood, urine and other body fluids. The liquid biopsies target one of the following:
  • Free circulating nucleic acids
  • microRNA from exosomes
  • circulating tumor cell released from cancers
The “Liquid biopsy” group is focused on:
  • the pre-analytical and analytical procedures and techniques for data normalization on the nucleic acids
  • enrichment, isolation, molecular
  • characterization of circulating tumor cells  
  • exosomes
  • quality of the results
Italian Scientific Societies will be also involved to define position and guidelines, and options about prime time to clinics